Fanconi anemia proteins and genome fragility: unraveling replication defects for cancer therapy.

Accurate and complete genome duplication is crucial to maintain cell survival and prevent malignant transformation. The Fanconi anemia (FA) pathway has traditionally been associated with the repair of DNA interstrand crosslinks that impede the progression of the replication machinery. Recent studies demonstrate that FA proteins also regulate cell-cycle checkpoints and/or promote replication fork remodeling in response to multiple DNA impediments, and redefine the FA pathway as a fundamental mechanism to preserve genome integrity upon different insults. Alterations in FA genes fuel genomic fragility and constitute a driving force of tumorigenesis. We highlight current understanding of FA signaling in safeguarding genome stability during replication, and discuss the identification of novel determinants of cancer cell survival in FA-deficient tumors. Copyright © 2022 Elsevier Inc. All rights reserved.

Citation

Nibal Badra Fajardo, Stavros Taraviras, Zoi Lygerou. Fanconi anemia proteins and genome fragility: unraveling replication defects for cancer therapy. Trends in cancer. 2022 Jun;8(6):467-481

Mesh Tags

Substances

PMID: 35232683

search → result